Effect of lysine hyaluronate on the healing of decubitus ulcers in rehabilitation patients

Advances in Therapy

Volumn 28, Issue 5, 2011, Pages 439-445

  Felzani, Giorgio ^a   Spoletini, Ilaria ^a   Convento, Alessia ^a   Di Lorenzo, Barbara ^a   Rossi, Pasqualino ^b   Miceli, Marco ^a   Rosano, Giuseppe ^a,c  

^a San Raffaele Sulmona   (Italy)

^b MINISTRY OF HEALTH   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

cardiovascular rehabilitation; decubitus ulcers; lysine hyaluronate

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; DERMATOLOGICAL AGENT; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; LYSIAL; LYSINE HYALURONATE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECUBITUS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHEMA; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION PATIENT; SKIN EDEMA; SKINFOLD THICKNESS; SUBCUTANEOUS TISSUE; TREATMENT DURATION; TREATMENT RESPONSE; ULCER HEALING;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; LYSINE; MALE; MIDDLE AGED; PRESSURE ULCER; TREATMENT OUTCOME; WOUND HEALING;

EID: 79958187011     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-011-0016-2     Document Type: Article

References (14)

1. Black J, Baharestani MM, Cuddigan J, et al. National Pressure Ulcer Advisory Panel's updated pressure ulcer staging system. Urol Nurs. 2007;27:144-150.
2. Cuddigan J, Frantz RA. Pressure ulcer research: pressure ulcer treatment: a monograph from the National Pressure Ulcer Advisory Panel. Adv Wound Care. 1998;11:294-300.
3. Reddy M, Gill SS, Kalkar SR, Wu W, Anderson PJ, Rochon PA. Treatment of pressure ulcers: a systematic review. JAMA. 2008;300:2647-2662.
4. Thomas DR. Does pressure cause pressure ulcers? An inquiry into the etiology of pressure ulcers. J Am Med Dir Assoc. 2010;11:397-405.
5. Reddy M, Gill SS, Rochon PA. Prevention of pressure ulcers: a systematic review. JAMA. 2006;296:974-984. (Pubitemid 44285374)
6. Whitney J, Phillips L, Aslam R, et al. Guidelines for the treatment of pressure ulcers. Wound Repair Regen. 2006;14:663-679. (Pubitemid 44951307)
7. European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel. Prevention and treatment of pressure ulcers: quick reference guide. Washington DC: National Pressure Ulcer Advisory Panel; 2009.
8. O'Regan M, Martini I, Crescenzi F, De Luca C, Lansing M. Molecular mechanisms and genetics of hyaluronan biosynthesis. Int J Biol Macromol. 1994;16:283-286.
9. Scott JE. Secondary structures in hyaluronan solutions: chemical and biological implications. Ciba Found Symp. 1989;143:6-15.
10. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27-33. (Pubitemid 27323862)
11. Norton D. Calculating the risk: reflections on the Norton scale. Decubitus. 1989;2:24.
12. Woodbury MG, Houghton PE. Prevalence of pressure ulcers in Canadian healthcare settings. Ostomy Wound Manage. 2004;50:22-24,26,28,30,32,34,36-38.
13. Ferrell BA, Josephson K, Norvid P, Alcorn H. Pressure ulcers among patients admitted to home care. J Am Geriatr Soc. 2000;48:1042-1047.
14. McDonald JA, Camenisch TD. Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J. 2002;19:331-339. (Pubitemid 37174563)